Literature DB >> 17157368

L-methamphetamine and selective MAO inhibitors decrease morphine-reinforced and non-reinforced behavior in rats; Insights towards selegiline's mechanism of action.

Shuangteng He1, Kenneth Grasing.   

Abstract

Selegiline is an inhibitor of type B monoamine oxidase (MAO) with psychostimulant effects that can decrease morphine-reinforced and non-reinforced responding. The present study was undertaken to compare the effects of MAO inhibition and treatment with L-methamphetamine, the major psychostimulant metabolite of selegiline, on these behaviors. After rats acquired a stable pattern of morphine self-administration under a progressive ratio schedule, chronic treatment was initiated with vehicle, L-methamphetamine, clorgyline (a selective inhibitor of MAO-A), or rasagiline (a selective inhibitor of MAO-B); with both MAO inhibitors administered at a dose selective for one MAO isoform and a higher dose that inhibited both isoforms. Rats were evaluated for up to four cycles of opiate dependence maintained by morphine self-administration and withdrawal during which extinction responding was recorded. Most behavioral measures (92.4%) did not differ in animals evaluated during an initial and subsequent cycles of dependence and withdrawal. All active treatments attenuated non-reinforced responding during extinction. Morphine reinforcement was also decreased by each of the three active treatments, but greater and more prolonged effects were observed following inhibition of MAO-B with rasagiline. Responding during either cue- or morphine-induced reinstatement was attenuated by either clorgyline or rasagiline administered at nonselective doses, but not by either compound administered at selective dose levels. Treatment with L-methamphetamine did not produce significant effects on cue-induced reinstatement, but decreased non-reinforced responding during morphine-induced reinstatement. These findings indicate that morphine reinforcement and different non-reinforced behaviors differ greatly in their susceptibility to modification by psychostimulant treatment or MAO inhibition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17157368     DOI: 10.1016/j.pbb.2006.10.022

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  9 in total

Review 1.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

2.  Multi-chemokine receptor antagonist RAP-103 inhibits opioid-derived respiratory depression, reduces opioid reinforcement and physical dependence, and normalizes opioid-induced dysregulation of mesolimbic chemokine receptors in rats.

Authors:  Angela R Bongiovanni; Pingwei Zhao; Saadet Inan; Sonita Wiah; Aryan Shekarabi; Daniel J Farkas; Mia N Watson; Mathieu E Wimmer; Michael R Ruff; Scott M Rawls
Journal:  Drug Alcohol Depend       Date:  2022-07-11       Impact factor: 4.852

3.  Dose-related effects of the acetylcholinesterase inhibitor tacrine on cocaine and food self-administration in rats.

Authors:  Kenneth Grasing; Shuangteng He; Yungao Yang
Journal:  Psychopharmacology (Berl)       Date:  2007-10-05       Impact factor: 4.530

4.  Chronic treatment with monoamine oxidase-B inhibitors decreases cocaine reward in mice.

Authors:  Ming-Che Ho; Chianfang G Cherng; Yen-Ping N Tsai; Chih-Yuan Chiang; Jia-Ying Chuang; Shu-Fang Kao; Lung Yu
Journal:  Psychopharmacology (Berl)       Date:  2009-04-03       Impact factor: 4.530

5.  N-Methyl, N-propynyl-2-phenylethylamine (MPPE), a Selegiline Analog, Attenuates MPTP-induced Dopaminergic Toxicity with Guaranteed Behavioral Safety: Involvement of Inhibitions of Mitochondrial Oxidative Burdens and p53 Gene-elicited Pro-apoptotic Change.

Authors:  Eun-Joo Shin; Yunsung Nam; Ji Won Lee; Phuong-Khue Thi Nguyen; Ji Eun Yoo; The-Vinh Tran; Ji Hoon Jeong; Choon-Gon Jang; Young J Oh; Moussa B H Youdim; Phil Ho Lee; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Mol Neurobiol       Date:  2015-11-13       Impact factor: 5.590

6.  Self administration of oxycodone by adolescent and adult mice affects striatal neurotransmitter receptor gene expression.

Authors:  B Mayer-Blackwell; S D Schlussman; E R Butelman; A Ho; J Ott; M J Kreek; Y Zhang
Journal:  Neuroscience       Date:  2013-11-09       Impact factor: 3.590

7.  Switch from selegiline to rasagiline is beneficial in patients with Parkinson's disease.

Authors:  Thomas Müller; Josef A Hoffmann; Walter Dimpfel; Christian Oehlwein
Journal:  J Neural Transm (Vienna)       Date:  2012-11-30       Impact factor: 3.575

8.  Aging reduces the sensitivity to the reinforcing efficacy of morphine.

Authors:  Angela R Bongiovanni; Kyle Peer; Rachel E Carpenter; Alexandra S Ellis; Michael R Duggan; Vinay Parikh; Mathieu E Wimmer
Journal:  Neurobiol Aging       Date:  2020-10-01       Impact factor: 4.673

9.  mRNA Levels of MAOA and 5-HT 2 A Receptor in Patients With Pathological Internet Use: Correlations With Comorbid Symptoms.

Authors:  Mimi Qiu; Chenchen Zhang; Yu Dai; Lingrui Zhang; Yang Wang; Wei Peng; Yalin Chen; Chao Wen; Hui Li; Tianmin Zhu
Journal:  Front Psychiatry       Date:  2021-07-16       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.